EXPLORING THE THERAPEUTIC POTENTIAL OF UMBILICAL CORD MESENCHYMAL STEM CELLS IN MODULATING TROPHOBLAST CELL FUNCTION FOR PREGNANCY-RELATED PLACENTAL DISORDERS
Main Article Content
Keywords
Preeclampsia, Intrauterine Growth Restriction, Trophoblast Cells, Umbilical Cord Mesenchymal Stem Cells, ell Therapy
Abstract
Preeclampsia and intrauterine growth restriction are disorders caused by dysfunctional trophoblast cells during pregnancy. Unfortunately, trophoblast cell function is little improved by treatments that target it. In addition to their ability to self-renew, to differentiate into a variety of cell types, and to possess paracrine properties, umbilical cord mesenchymal stem cells (hUCMSCs) have a number of immunomodulatory properties, making them a potential source for cell therapy. We used hUCMSC supernatants or cocultured hUCMSCs with trophoblast cells to determine whether hUCMSCs could influence trophoblast cell functions. A remarkable difference existed between the two treatments in terms of trophoblast cells' migration and invasion capacities, as well as their ability to proliferate. As well, hUCMSCs modulated the levels of hCG, PIGF, and sEndoglin in trophoblast culture medium when a concentration of hUCMSCs is applied. Through improving trophoblast cellular functions, hUCMSCs may be used to treat pregnancy-related placental diseases.
References
2. M. Hemberger, “Health during pregnancy and beyond: fetal trophoblast cells as chief co-ordinators of intrauterine growth and reproductive success,” Annals of Medicine, vol. 44, no. 4, pp. 325–337, 2012.
3. E. Staun-Ram and E. Shalev, “Human trophoblast function during the implantation process,” Reproductive Biology and Endocrinology, vol. 3, article 56, 2005.
4. R. Romero and T. Chaiworapongsa, “Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state, The Journal of Clinical Investigation, vol. 123, no. 7, pp. 2775– 2777, 2013.
5. C.W. Redman and I. L. Sargent, “Latest advances in understanding preeclampsia,” Science, vol. 308, no. 5728, pp. 1592–1594, 2005.
6. S. Saito and A. Nakashima, “A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling,” Journal of Reproductive Immunology, vol. 101-102, no. 1, pp. 80–88, 2014.
7. E. Fossett and W. S. Khan, “Optimising human mesenchymal stem cell numbers for clinical application: a literature review,” Stem Cells International, vol. 2012, Article ID 465259, 5 pages,
8. 2012.
A. K. Batsali, M.-C. Kastrinaki, H. A. Papadaki, and C. Pontikoglou, “Mesenchymal stem cells derived from Wharton’s Jelly of the umbilical cord: biological properties and emerging clinical applications,” Current Stem Cell Research and Therapy, vol. 8, no. 2, pp. 144–155, 2013.
9. L. Liu, G. Zhao, H. Fan et al., “Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-???? expression,” PLoS ONE, vol. 9, no. 2, Article ID e88036, 2014.
10. J. H. Choi, J. Jung, K.-H. Na, K. J. Cho, T. K. Yoon, and G. J. Kim, “Effect of mesenchymal stem cells and extracts derived from the placenta on trophoblast invasion and immune responses,” Stem Cells and Development, vol. 23, no. 2, pp. 132–145, 2014.
11. R. El Omar, J. Beroud, J.-F. Stoltz, P. Menu, E. Velot, and V. Decot, “Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?” Tissue Engineering B: Reviews, vol. 20, no. 5, pp. 523–544, 2014.
12. M. L. Weiss, C. Anderson, S. Medicetty et al., “Immune properties of human umbilical cord Wharton’s jelly-derived cells,” Stem Cells, vol. 26, no. 11, pp. 2865–2874, 2008.
13. D. L. Troyer and M. L. Weiss, “Wharton’s Jelly-derived cells are a primitive stromal cell population,” Stem Cells, vol. 26, no. 3, pp. 591–599, 2008.
14. T. Nagamura-Inoue and H. He, “Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility,” World Journal of Stem Cells, vol. 6, no. 2, pp. 195–202, 2014.
15. T. Takao, K. Asanoma, K. Kato et al., “Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line,” PLoS ONE, vol. 6, no. 7, Article ID e21990, 2011.
16. M. Weber, I. Knoefler, E. Schleussner, U. R. Markert, and J. S. Fitzgerald, “HTR8/SVneo cells display trophoblast progenitor cell-like characteristics indicative of self-renewal, repopulation activity, and expression of “stemness-” associated transcription factors,” BioMed Research International, vol. 2013, Article ID 243649, 10 pages, 2013.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Praveen Kumar
Assistant Professor, Department of Anatomy,Saraswathi Institute of Medical Science, Anwarpur, Hapur District - 245304